Takeda is fourth big company to leave BIO since December
Takeda Pharmaceuticals has left BIO, the fourth departure of a major member since December, the company confirmed.
Takeda Pharmaceuticals has left BIO, the fourth departure of a major member since December, the company confirmed.
Practice Network, a new initiative, aims to help smaller hospitals implement AI tools in local settings where adoption is currently stymied.
This essay describes the author’s experience of improved patient care and collaboration the day the the electronic medical records system went down.
This 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and…
This cohort study examines prespecified health outcomes after vaccination with an ancestral monovalent COVID-19 vaccine in US children aged 6 months to 17 years.
This survey study examines preferences and willingness to pay for facility-based vs home-based postacute care among patients and caregivers.
Can AI/machine learning-driven digital phenotyping facilitate global personalized medicine? In this Q&A, Vikram Patel, MBBS, PhD, the Paul Farmer Professor and chair of the Department…
JAMA Health Forum Editor John Ayanian, MD, MPP, speaks with Kelsey M. Owsley, PhD, of the University of Arkansas, and Sayeh Nikay, PhD, MPH, of…
The news that Sarah Benn has been suspended from the medical register sends a bleak message to climate concerned younger doctors, writes Alexander Mafi Doctors…
SCOOP: The Trump administration quietly spent $10 billion from a fund Congress created to help health care providers with Covid-19 costs, and used it on…
New studies point to potential for greater reliance on objective imaging biomarkers for accurate diagnosis of multiple sclerosis.